Skip to content

Sight Sciences, Inc. SGHT Interest coverage

Interest coverage at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
24.5×-1.7×
Glaukos logo
GlaukosGKOS
-43.2×-78.6×
Bausch + Lomb logo
Bausch + LombBLCO
0.5×+0.4×
Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
-5.7×-2.0×
Boston Scientific logo
Boston ScientificBSX
10.6×+1.7×

Other financials

Income statement

See full
Revenue$19.7M+12.5%
Gross profit$17.0M+12.5%
Operating income-$12.4M+10.4%
Net income-$13.0M+8.3%
EPS (diluted)-$0.24+14.3%

Balance sheet

See full
Cash & equivalents$85.0M-21.9%
Total debt$40.9M+1.1%
Total equity$53.9M-30.6%
Total assets$109.7M-15.4%

Cash flow

See full
Operating cash flow-$7.0M+39.4%
CapEx$60.0K
Free cash flow-$7.1M+38.9%

Valuation

See full
Market cap$294.9M+35.0%
Enterprise value$250.83M+59.0%
P/S3.7×+0.8×

Profitability

See full
Gross margin86.2%+0.5pp
Operating margin-44.8%-10.2pp
Net margin-46.8%-9.6pp
FCF margin-31.9%+0.2pp

Returns & leverage

See full
Return on equity-56.6%+4.3pp
Debt / equity0.8×+0.2×
Current ratio5.9×-4.6×

Where this comes from

Calculated from Sight Sciences, Inc.’s reported figures.

Based on trailing twelve months.

The official record: Sight Sciences, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sight Sciences, Inc.'s interest coverage.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sight Sciences, Inc.'s interest coverage?
Sight Sciences, Inc. (SGHT) reported interest coverage of -6.9× in Q1 2026.
How has Sight Sciences, Inc.'s interest coverage changed year-over-year?
Sight Sciences, Inc.'s interest coverage increased by 34.2% year-over-year, from -10.5× to -6.9×.
What is the long-term trend for Sight Sciences, Inc.'s interest coverage?
Over 5 years (2020 to 2025), Sight Sciences, Inc.'s interest coverage has grown at a -11.6% compound annual growth rate (CAGR), from -13.4× to -7.2×.
What does interest coverage mean?
Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.